EX-10.25






 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  

 Exhibit 10.25 

Voting Proxy Agreement 
 This Voting
Proxy Agreement (this “Agreement”) is executed by and among the following Parties on November 21, 2018 in Shanghai, the People’s Republic of China (“PRC”): 

Shenzhen Pingan Financial Technology Consultation Company, a limited liability company organized and existing under the laws of PRC, with its address
at the fourth floor, Bagualingbaguasan Road, Futian District, Shenzhen (“Pingan Jinke”). 
 Shanghai Lanbang Investment Company, a
limited liability company organized and existing under the laws of PRC, with its address at 1002N, No. 2277 Longyang Road, Pudong New District, Shanghai (“Shanghai Lanbang”). 

Xinjiang Tongjun Equity Investment Limited Partnership, a limited partnership organized and existing under the laws of PRC, with its address at
No. 46, Floor 4, No.21 Xiamen Road, Economic and technological Development District„ Urumchi, Xinjiang (“Xinjiang Tongjun”). 

Linzhi Jinsheng Investment Management Limited Partnership, a limited partnership organized and existing under the laws of PRC, with its address at 3-301, Price Bureau, Gongbujiangda County, Linzhi District, Tibet (“Linzhi Jinsheng”, Pingan Jinke, Shanghai Lanbang, Xinjiang Tongjun, and Linzhi Jinsheng, collectively as the
“Principal”). 
 Lufax Holding (Shenzhen) Technology Service Co., Ltd., a limited liability company organized and existing under the
laws of PRC, with its address at Room A201, No.1, Qianwan Yi Road, Qianhai Shenzhen-Hongkong Modern Service Industry Cooperation Zone, Shenzhen (settled in Shenzhen Qianhai Business Secretary Co., Ltd.)
(“Lufax Holding (Shenzhen) Technology”). The equity interests of Lufax Holding (Shenzhen) Technology Service Co., Ltd. is indirectly held by Lufax Holding Ltd (“Ultimate Controlling Shareholder”), an exempted
company with limited liabilities in the Cayman Islands. 
 Shenzhen Lufax Holding Enterprise Management Co., Ltd., a limited liability company
organized and existing under the laws of PRC, with its address at Room A201, No.1, Qianwan Yi Road, Qianhai Shenzhen-Hongkong Modem Service Industry Cooperation Zone, Shenzhen (settled in Shenzhen Qianhai
Business Secretary Co., Ltd.) (the “OPCO”). 
 Yang Xuelian, a Chinese citizen, ID card number is [***]. 

Shi Jingkui, a Chinese citizen, ID card number is [***]. 

Wang Wenjun, a Chinese citizen, ID card number is [***]. 

Dou Wenwei, a Chinese citizen, ID card number is [***]. 

(Yang Xuelian, Shi Jingkui, Wang Wenjun, and Dou Wenwei, collectively as the “Individual Shareholders”; the Individual Shareholders and the
Principal, together as the “Shareholders”.) 

  
 1 


  














 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  

 In this Agreement, above shall be referred to as a “Party” respectively, and they shall be
collectively referred to as the “Parties”. 
 Whereas: 

The Principal are the registered shareholders of the OPCO and collectively holds 100 % of the equity interests in the OPCO (the
“Shares”); 
 The OPCO and Lufax Holding (Shenzhen) Technology entered into the Exclusive Business Cooperation Agreement on
November 21, 2018 (the “Service Agreement”); 
 The Shareholders entered into this Agreement to agree and confirm that the Principal
shall grant (i) Lufax Holding (Shenzhen) Technology; (ii) the directors authorised by Lufax Holding (Shenzhen) Technology and their successors; and (iii) any liquidator replacing the directors of Lufax Holding (Shenzhen) Technology
(the entities and individuals referred to under aforesaid (i), (ii) and (iii), collectively, the “Proxy”) the power to exercise all rights of the OPCO’s shareholders on behalf of the Principal; and 

The Individual Shareholders each executed an individual shareholder’s undertaking (the “Individual Shareholder Undertaking”) in writing
in relation to this Agreement and the rights and interests indirectly held by him/her in the OPCO to the board of directors of the Ultimate Controlling Shareholder on the date of this Agreement. 

Now therefore, upon mutual discussion and negotiation, the Parties have reached the following agreement: 

 

	1.	 Voting Rights and Other Shareholder Rights 



 

	 	1.1	 According to the conditions and terms hereunder, the Principal shall authorize the Proxy to exercise on behalf
of the Principal all of its rights as a shareholder of the OPCO in accordance with the laws of China and the OPCO’s articles of association, including but not limited to the following: 



 

	 	(1)	 propose, convene and attend the shareholders’ meetings of OPCO; 



 

	 	(2)	 Exercise shareholders’ voting rights, including but not limited to any sale, transfer, pledge or disposal
of the Shares in part or in whole, and participate in dividend distributions or any other type of distributions of the OPCO; 


  

	 	(3)	 designate and appoint the legal representative (chairperson), the director, supervisor, the chief executive
officer (or general manager) and other senior management members of the OPCO; 


  

	 	(4)	 sign minutes and file documents with the relevant companies registry; and 



 

	 	(5)	 exercise voting rights on the winding up of the OPCO on behalf of the Principal. 



  
 2 


  














 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  


	 	1.2	 For Proxy’s effective implementation and exercise of each power and right granted under Article 1 above,
the Indirect Shareholders and the Principal hereby undertake and agree as follows: 


  

	 	1.2.1	 If any law, regulation, or government body requires Principal to issue or execute special power of attorney,
governmental application documents, or similar documents or requires Principal to carry out related procedures (such as notarization of power of attorney) with respect to a specific matter under entrustment, the Principal shall immediately issue
and/or cooperate to execute related documents per such requirements; and 


  

	 	1.2.2	 The Principal shall promptly take all necessary actions to procure and ensure the due implementation of all the
resolutions made by the Proxy in a board of directors’ meeting or shareholders’ meeting of the OPCO. The Principal shall not, in the capacity of the OPCO’s shareholder, delay or refuse the passing and/or implementation of any said
resolution of the OPCO. 


  

	 	1.3	 For the effective exercise of the powers and rights granted to the Proxy under Article 1.1, the OPCO hereby
undertakes and agrees as follows: 


  

	 	1.3.1	 Subject to applicable laws and regulations, the OPCO shall implement all the resolutions made by the Proxy in a
board of directors’ meeting or a shareholders’ meeting of the OPCO, including but not limited to the immediate provision and/ or the execution of relevant documents as required by the Proxy; 



 

	 	1.3.2	 The OPCO shall assist the Proxy with understanding the details of its operation. The OPCO shall provide the
Proxy with any corporate books, accounts, records and other documents. The Proxy is entitled to make extracts or photocopies of such books, accounts, records and other documents; and 



 

	 	1.3.3	 The OPCO shall provide all other necessary assistance, including but not limited to promptly signing the
shareholders’ resolution of the OPCO made by Proxy and other relevant legal documents when necessary (such as to meet the government authorities’ request on documents required for approval, registration and filing). 



 

	 	1.4	 Without limiting the generality of the powers and rights granted hereunder, the Proxy shall have the power and
authority under this Agreement to execute the Tranfer Agreements stipulated in the Exclusive Equity Interest Option Agreement and Exclusive Assets Option Agreement, to which the Principal are required to be a party thereof, on behalf of the
Principal, and to exercise and perform the rights and obligations under the Share Pledge Agreement, Exclusive Equity Interest Option Agreement and Exclusive Asset Option Agreement, to which the Principal are the party. For purpose of the aforesaid,
the “Share Pledge Agreement”, “Exclusive Equity Interest Option Agreement” and “Exclusive Asset Option Agreement” shall respectively refer to the relevant agreement entered into among the Principal,
OPCO, the Proxy, and other parties (if applicable) on the date hereof. 



  
 3 


  














 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  


	 	1.5	 The exercise of the rights attached to the Shares by the Proxy shall be deemed as the actions of the Principal,
and all the documents related thereto executed by the Proxy shall be deemed to be executed by the Principal. When acting in respect of any and all of the aforementioned matters, the Proxy may act at its own discretion and does not need to seek the
prior consent of the Principal or any Shareholder. The Shareholders and the Principal hereby acknowledge and ratify those actions and/or documents by the Proxy and acknowledge and accept the legal consequences arising therefrom.



  

	 	1.6	 The Indirect Shareholders and the Principal agree and acknowledge that under no circumstances shall the Proxy
be required to be held liable to or make economic or other compensations for any other or third parties as a result of its exercise of the rights granted hereunder. The Indirect Shareholders and the Principal agree to indemnify the Proxy and
hold it harmless from any and all losses that are or may be incurred by the Proxy as a result of the exercise by it of the rights granted hereunder, including but not limited to the losses arising from any actions, recourses, arbitrations,
claims or government investigations or punishments filed against it by any third parties, unless such losses are incurred as a result of the Proxy’s gross negligence or willful misconduct. 



 

	 	1.7	 Within the term of this Agreement, without the prior written consent of the Proxy, the Principal shall neither
terminate this Agreement early or rescind this Agreement nor take any actions or inactions against or inconsistent with the exercise by the Proxy of the powers and rights granted to it under Article 1.1. 



 

	 	1.8	 Within the term of this Agreement, the Principal shall not procure the OPCO to, or take any action against or
inconsistent with the resolutions made by the Proxy in a board of directors’ meeting or a shareholders’ meeting of the OPCO. 


  

	 	1.9	 The Principal shall not take any action to dispute, challenge, contest or work against the validity and
enforceability of the Service Agreement and this Agreement and of the transactions contemplated under the Service Agreement and this Agreement. 


  

	 	1.10	 If any operation or decision of the OPCO is subject to the approval by the Principal in the capacity of
shareholder, without the prior written consent of the Proxy, the Principal shall not vote to approve such operation or decision. 


  

	 	1.11	 Without the prior written consent of the Proxy, the Principal shall not enter into any contract or agreement
binding upon the OPCO or take any action increasing the obligation of the OPCO or in breach of this Agreement. 


  

	 	1.12	 During the term of this Agreement, the Principal hereby waives all the powers and rights associated with the
Shares, which have been granted to the Proxy hereunder, and shall not exercise such powers and rights on its own. 



  
 4 


  














 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  


	 	1.13	 (i) The inheritor of any Individual Shareholder or (ii) the individual or legal person designated by Lufax
Holding (Shenzhen) Technology pursuant to the Individual Shareholder Undertaking executed by the relevant Individual Shareholder (the “Designated Transferee”) shall undertake any and all the rights and obligations of the relevant
Individual Shareholder under this Agreement as a result of his/her death, incapacitation or any other circumstances which could affect his/her holding or exercising his/her equity indirect interests in the Principal and the OPCO, as if the inheritor
or Designated Transferee were a signing party to this Agreement. Under the circumstance of an inheritance or share transfer pursuant to the relevant Individual Shareholder Undertaking, the Shareholders shall complete all necessary procedures and
take all necessary actions to procure the required government approval (if applicable) being obtained for such share transfer. 


  

	 	1.14	 So long as a Principal or its successor (s) is/are an equity holder of, or has control over, the OPCO,
this Agreement shall be irrevocably and continuously valid and effective from the date of its execution, unless the Proxy otherwise advises in writing. 


  

	2.	 Representations and Warranties 



The Shareholders and the OPCO each represents and warrants to the Proxy that 

 

	 	(a)	 it has all the powers and capacities to enter into this Agreement and perform all the obligations and duties
hereunder; 


  

	 	(b)	 its performance of the obligations and duties hereunder is legal, valid, binding and enforceable pursuant to
the terms thereof; 


  

	 	(c)	 carry out and satisfy all actions, conditions and events that shall be carried out, satisfied or implemented
(including obtaining all necessary consents, approvals and authorizations, if required by law) so that 


  

	 	(i)	 it may legally enter into this Agreement, exercise its rights hereunder, and perform and comply with its
obligations and duties hereunder; 


  

	 	(ii)	 it can ensure its obligations and duties hereunder are legal, valid and binding; and 



 

	 	(iii)	 this Agreement becomes admissible evidence under the applicable laws. 



 

	 	(d)	 its entering into of this Agreement, exercise of the rights hereunder, and performance and compliance of the
obligations and duties hereunder neither breach or contravene any of the following or exceed any powers or restrictions granted or imposed by any of the following: 



 

	 	(i)	 any laws, ordinances, regulations, or rules, any judgments, orders or arbitrations, or any consents, approvals
or authorizations that it shall comply with; or 



  
 5 


  














 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  


	 	(ii)	 its articles of association or any provision of any other applicable document or constitutional document; or



  

	 	(iii)	 any provision in any agreement or document to which it is a party or by which any of its assets is bound.



  

	 	(e)	 it has obtained all the approvals and authorizations from any government or other organizations (if so required
by law) or any of its proxies that are necessary for the entering into and execution and the validity of this Agreement, and all the approvals and authorizations are fully effective. 



 

	3.	 Severability 



In the event that one or several of the provisions of this Agreement are found to be invalid, illegal or unenforceable in any aspect in
accordance with any laws or regulations, the validity, legality or enforceability of the remaining provisions of this Agreement shall not be affected or compromised in any respect. The Parties shall strive in good faith to replace such invalid,
illegal or unenforceable provisions with effective provisions that accomplish to the greatest extent permitted by law and the intentions of the Parties, and the economic effect of such effective provisions shall be as close as possible to the
economic effect of those invalid, illegal or unenforceable provisions. 
  

	4.	 Term of Authorization 



The term of authorization of the powers and rights to the Proxy hereunder shall be the same as that of the Service Agreement executed between
the Proxy and the OPCO. 
  

	5.	 Notices 



 

	 	5.1	 All notices and other communications required or permitted to be given pursuant to this Agreement shall be
delivered personally or sent by registered mail, postage prepaid, by a commercial courier service or by facsimile transmission to the address of such Party set forth below. A confirmation copy of each notice shall also be sent by email. The dates on
which notices shall be deemed to have been effectively given shall be determined as follows: 


  

	 	(i)	 Notices given by personal delivery, by courier service or by registered mail, postage prepaid, shall be deemed
effectively given on the date of delivery or refusal at the address specified for notices. 


  

	 	(ii)	 Notices given by facsimile transmission shall be deemed effectively given on the date of successful
transmission (as evidenced by an automatically generated confirmation of transmission). 


  

	 	5.2	 For the purpose of notices, the addresses of the Parties are as follows: 



 

			
	 Company:
	  	 Shenzhen Lufax Holding Enterprise Management Co., Ltd.

	 Address:
	  	 [***]

	 Attn:
	  	 [***]




  
 6 


  














 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  

 
			
	 Company:
	  	 Lufax Holding (Shenzhen) Technology Service Co., Ltd.

	 Address:
	  	 [***]

	 Attn:
	  	 [***]

		
	 Company:
	  	 Shenzhen Pingan Financial Technology Consultation Company

	 Address:
	  	 [***]

	 Attn:
	  	 [***]

		
	 Company:
	  	 Shanghai Lanbang Investment Company

	 Address:
	  	 [***]

	 Attn:
	  	 [***]

		
	 Company:
	  	 Xinjiang Tongjun Equity Investment Limited Partnership

	 Address:
	  	 [***]

	 Attn:
	  	 [***]

		
	 Company:
	  	 LinzhiJinsheng Investment Management Limited Partnership

	 Address:
	  	 [***]

	 Attn:
	  	 [***]

		
	 Name:
	  	 Yang Xuelian

	 Address:
	  	 [***]

		
	 Name:
	  	 Shi Jingkui

	 Address:
	  	 [***]

		
	 Name:
	  	 Wang Wenjun

	 Address:
	  	 [***]

		
	 Name:
	  	 Dou Wenwei

	 Address:
	  	 [***]



  

	 	5.3	 Any Party may at any time change its address for notices by a notice delivered to the other Parties in
accordance with the terms hereof. 



  
 7 


  














 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  


	6.	 Confidentiality 



The Parties acknowledge that any oral or written information exchanged among them with respect to this Agreement is confidential information.
Each Party shall maintain the confidentiality of all such information, and without obtaining the written consent of other Parties, it shall not disclose any relevant information to any third parties, except in the following circumstances:
(a) such information is or will be in the public domain (provided that this is not the result of a public disclosure by the receiving Party); (b) information disclosed as required by applicable laws or rules or regulations of any stock
exchange; or (c) information required to be disclosed by any Party to its legal counsel or financial advisor regarding the transaction contemplated hereunder, and such legal counsel or financial advisor are also bound by confidentiality duties
similar to the duties in this Section. Disclosure of any confidential information by the staff members or agency hired by any Party shall be deemed disclosure of such confidential information by such Party, which Party shall be held liable for
breach of this Agreement. This Section shall survive the termination of this Agreement for any reason. 
  

	7.	 Governing Law, Resolution of Disputes and Chance in Laws 



 

	 	7.1	 The execution, effectiveness, construction, performance, amendment and termination of this Agreement and the
resolution of disputes hereunder shall be governed by the formally published and publicly available laws of China. Matters not covered by formally published and publicly available laws of China shall be governed by international legal principles and
practices. 


  

	 	7.2	 In the event of any dispute with respect to the construction and performance of the provisions of this
Agreement, the Parties shall negotiate in good faith to resolve the dispute. In the event the Parties fail to reach an agreement on the resolution of such a dispute within 30 days after any Party’s request for resolution of the dispute through
negotiations, any Party may submit the relevant dispute to the China International Economic and Trade Arbitration Commission (“CIETAC”) for arbitration, in accordance with its then-effective arbitration rules. The arbitration shall
be conducted in Shanghai, and the language used during arbitration shall be Chinese. The arbitration ruling shall be final and binding on all Parties. 


  

	 	7.3	 Upon the occurrence of any disputes arising from the construction and performance of this Agreement or during
the pending arbitration of any dispute, except for the matters under dispute, the Parties to this Agreement shall continue to exercise their respective rights under this Agreement and perform their respective obligations under this Agreement.



  

	 	7.4	 In case of promulgation or any change to or in any Chinese law, regulation or rule, or any change to or in the
interpretation or application of the same anytime after execution of this Agreement, the following agreement shall apply: (a) if any Party would enjoy more benefits under any changed or new law than under the relevant law, regulation or rule in
effect at the date of this Agreement, without any material adverse effect upon the other Parties, the Parties shall promptly apply for such benefits brought by the changed or new law. The Parties shall make best efforts to procure the approval of
such application; and (b) if the aforementioned law change or promulgation causes any direct or indirect material adverse effect to either Party, all Parties shall try all lawful means to procure exemption from compliance with such changed or
new law provisions and use their best efforts to implement this Agreement in accordance with its original terms and conditions. In the event such adverse effect on the economic interest of either Party is unable to be resolved pursuant to this
Agreement, the affected Party may give notice to the other Parties, and the Parties shall hold prompt discussion and make all necessary amendments to this Agreement so as to maintain the economic benefits otherwise enjoyed by the affected Party to
the extent permitted under PRC laws. 



  
 8 


  














 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  


	 	7.5	 Subject to PRC laws, the arbitration tribunal may award remedies over the shares or land assets of Principal,
injunctive relief (including but not limited to matters of business or compel the transfer of assets) or award the winding-up of Principal. Any party shall have the right to apply for enforcement of
arbitration awards to the court with jurisdiction after the arbitration awards come into force. Subject to PRC laws, at the request of a disputing party, the court of competent jurisdictions shall have the power to grant interim remedies in support
of the arbitration pending formation of the arbitral tribunal or in appropriate cases permitted by laws as the property preservation or enforcement measures. Subject to PRC laws, the courts of (i) Hong Kong, (ii) the Cayman Islands,
(iii) the place of incorporation of OPCO (i.e. Shenzhen, PRC); and (iv) the place (s) where the Ultimate Controlling Shareholder or OPCO’s principal assets are located shall have jurisdiction for the aforesaid purpose.



  

	8.	 Assignment 



 

	 	8.1	 Without Proxy’s prior written consent, Shareholders or the OPCO shall not assign its rights and
obligations under this Agreement to any third party. 


  

	 	8.2	 Lufax Holding (Shenzhen) Technology is entitled to re-authorize or
assign rights to its directors, managers or other employees authorized by the Principal, at their own discretion and without giving prior notice to the Principal or obtaining the Principal’ consent. 



 

	9.	 Amendment Chance and Supplement 



 

	 	9.1	 Any amendment, change and supplement to this Agreement shall require the execution of a written agreement by
all of the Parties. 


  

	 	9.2	 If the Stock Exchange of Hong Kong Limited (“SEHK”) or any other relevant regulatory authority
or stock exchange requests any amendment to this Agreement or if there is any change to the Rules Governing the Listing of Securities on the SEHK or any other relevant stock exchange rules that is relevant to the terms of this Agreement, the Parties
shall make corresponding changes to the terms of this Agreement. 


  

	10.	 Survival 



 

	 	10.1	 Any obligations that occur or that are due as a result of this Agreement upon the expiration or early
termination of this Agreement shall survive the expiration or early termination thereof. 



  
 9 


  














 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  


	 	10.2	 The provisions of Sections 5, 7 and this Section 10 shall survive the termination of this Agreement.



  

	11.	 Miscellaneous 



 

	 	11.1	 This Agreement is written in Chinese and the English translation is for reference only. In case there is any
inconsistency between the Chinese version and the English version, the Chinese version shall prevail. This Agreement shall be executed in 15 counterparts, with each Party having one original and the Principal having the others; each counterpart has
equal legal validity. 


  

	 	11.2	 This Agreement is binding on the legitimate assigns and successors of all Parties. 



 

	 	11.3	 Except for the amendments, supplements or changes in writing executed after the execution of this Agreement,
this Agreement shall constitute the entire agreement reached by and among the Parties hereto with respect to the subject matter hereof, and shall supersede all prior oral and written consultations, representations and contracts reached with respect
to the subject matter of this Agreement. 


 [The space below is intentionally left blank] 

  
 10 


  














 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  

 IN WITNESS WHEREOF, the Parties have caused their authorized representatives to execute this Voting Proxy
Agreement as of the date first above written. 
  

			
	Lufax Holding (Shenzhen) Technology Service Co., Ltd
		
	By:	 	 /s/ Gregory Dean Gibb

		 	Name: Gregory Dean Gibb
		 	Title:   Legal Representative



  
 SIGNATURE PAGE TO VOTING
PROXY AGREEMENT 


  














 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  

 IN WITNESS WHEREOF, the Parties have caused their authorized representatives to execute this Voting Proxy
Agreement as of the date first above written. 
  

			
	Shenzhen Lufax Holding Enterprise Management Co., Ltd.
		
	By:	 	 /s/ Li Renjie

		 	Name: Li Renjie
		 	Title:   Legal Representative



  
 SIGNATURE PAGE TO VOTING
PROXY AGREEMENT 


  














 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  

 IN WITNESS WHEREOF, the Parties have caused their authorized representatives to execute this Voting Proxy
Agreement as of the date first above written. 
  

			
	Shenzhen Pingan Financial Technology Consultation Company
		
	By:	 	 /s/ Zhou Tingyuan

		 	Name: Zhou Tingyuan
		 	Title:   Legal Representative



  
 SIGNATURE PAGE TO VOTING
PROXY AGREEMENT 


  














 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  

 IN WITNESS WHEREOF, the Parties have caused their authorized representatives to execute this Voting Proxy
Agreement as of the date first above written. 
  

			
	Shanghai Lanbang Investment Company
		
	By:	 	 /s/ Shi Jingkui

		 	Name: Shi Jingkui
		 	Title:   Legal Representative



  
 SIGNATURE PAGE TO VOTING
PROXY AGREEMENT 


  














 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  

 IN WITNESS WHEREOF, the Parties have caused their authorized representatives to execute this Voting Proxy
Agreement as of the date first above written. 
  

			
	Xinjiang Tongjun Equity Investment Limited Partnership
		
	By:	 	 /s/ Dou Wenwei

		 	Name: Dou Wenwei
		 	Title:   Managing Partner



  
 SIGNATURE PAGE TO VOTING
PROXY AGREEMENT 


  














 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  

 IN WITNESS WHEREOF, the Parties have caused their authorized representatives to execute this Voting Proxy
Agreement as of the date first above written. 
  

			
	Linzhi Jinsheng Investment Management Limited Partnership
		
	By:	 	 /s/ Yang Xuelian

		 	Name: Yang Xuelian
		 	Title: Managing Partner



  
 SIGNATURE PAGE TO VOTING
PROXY AGREEMENT 


  














 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  

 IN WITNESS WHEREOF, the Parties have caused their authorized representatives to execute this Voting Proxy
Agreement as of the date first above written. 
  

			
	By:	 	 /s/ Yang Xuelian

		 	Name: Yang Xuelian



  
 SIGNATURE PAGE TO VOTING
PROXY AGREEMENT 


  














 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  

 IN WITNESS WHEREOF, the Parties have caused their authorized representatives to execute this Voting Proxy
Agreement as of the date first above written. 
  

			
	By:	 	 /s/ Shi Jingkui

		 	Name: Shi Jingkui



  
 SIGNATURE PAGE TO VOTING
PROXY AGREEMENT 


  














 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  

 IN WITNESS WHEREOF, the Parties have caused their authorized representatives to execute this Voting Proxy
Agreement as of the date first above written. 
  

			
	By:	 	 /s/ Dou Wenwei

		 	Name: Dou Wenwei



  
 SIGNATURE PAGE TO VOTING
PROXY AGREEMENT 


  














 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  

 IN WITNESS WHEREOF, the Parties have caused their authorized representatives to execute this Voting Proxy
Agreement as of the date first above written. 
  

			
	By:	 	 /s/ Wang Wenjun

		 	Name: Wang Wenjun



  
 SIGNATURE PAGE TO VOTING
PROXY AGREEMENT